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ABSTRACT 
The aim of this study was to overcome pH-dependent release of weakly basic drug and to achieve pH-independent 
drug release. An anti-hypertensive drug, Propranolol hydrochloride was chosen due to its pH- dependent solubility. 
One of the approaches to solve the problem of pH-dependent release of weakly basic drug has been done in this work. 
The water soluble and  highly  swellable HPMC  was used  as a  matrix  former and organic acids Citric acid and 
Succinic acid were added to the drug polymer system in different formulations in varying proportions (at 10, 20, 40 
and 80mg) as release modifiers. The addition of organic acids was found to maintain an acidic micro environmental 
pH inside the polymer matrices during drug release in phosphate buffer pH 7.4. On the other hand, the amount of 
each organic acid added to the system had no effect on the drug release in acidic solution 0.1N HCL. So the micro 
environmental conditions for the dissolution and diffusion of drug were almost kept constant. Thus, the release of 
Propranolol  hydrochloride  from  tablets  containing  HPMC  and  organic  acids  was  found  to  be  pH-Independent. 
Between the two organic acids, Succinic acid showed slightly better release when compared to Citric acid.  
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INTRODUCTION 
Many  drugs  are  weak  bases  or  salts  thereof  and  thus 
demonstrate pH dependent solubility in the pH range of 
the  GI  tract
1.  With  controlled  release  dosage  forms,  a 
possible  pH-dependent  release  could  result  in  in-vivo 
variability  and  bioavailability  problems.    Hence  pH-
independent drug release is desirable to better assure a 
reliable drug therapy and to build a greater control into a 
dosage form. 
Several  attempts  to  overcome  the  problem  of  pH 
dependent  solubility  of  weakly  basic  drugs  have  been 
published
2.  They are mostly based on the presence of 
acidic  Excipients  such  as  water-soluble  or  insoluble 
polymers  or  organic  acids
3  that  either  increases  the 
permeability of the drug delivery system by leaching out 
at  higher  pH-values  or  which  keep  the  pH  within  the 
system  in  the  intestinal  pH-range  low  and  thus  the 
solubility of the drug high. 
The  objective  of  this  study  is  to  achieve  a  pH-
independent release of a weakly basic drug from matrix 
tablets  consisting  of  HPMC,  a  swellable  and  water-
soluble polymer
4. One of the approaches to overcome the 
problem  of  pH-dependent  drug  release  has  been 
demonstrated  in  this  work,  i.e.,  using  organic  acids 
(Citric  acid,  Succinic  acid)  to  create  an  acidic  micro-
environmental  pH  inside  the  polymer  matrices
5.  
Propranolol  HCl  is  an  adrenergic  blocking  agent, 
effective  in  treatment  of  hypertension  and  angina. 
Propranolol  HCl  has  short  plasma  half-life  of  3-5hrs 
owing to which, multiple doses are needed to maintain 
therapeutic concentration of the drug in plasma for better 
therapeutic response and  improved patient compliance. 
Therefore,  it  is  necessary  to  develop  sustained  release 
preparations with extended clinical effects
6, 7. 
MATERIALS AND METHODS 
The  materials  used  were  procured  from  the  following 
sources:  Propranolol  hydrochloride  (Zydus  Cadila 
pharmaceuticals ltd. -Bangalore), Hydroxy propyl methyl 
cellulose (HPMC, Methocelâ, K-15M, BPRL Pvt. Ltd. 
Bangalore),  Magnesium  stearate  (Loba  chemie  - 
Mumbai),  lactose  (Fast  flow,  Pharmatose,  Nice 
chemicals)  citric  acid,  Succinic  acid  (Nice  chemicals-
Cochin) and all the other reagents used were laboratory 
grade. Magnesium stearate was used as lubricant. After 
evaluating the pre-compression parameters the lubricated 
granules were compressed using 10-station Rimek mini-Jayanthi et al / IJRAP 2011, 2 (2) 577-580 
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press  RSB-4  tablet  punching  machine  using  8mm 
diameter concave punches. The total weight of the tablet 
was maintained at 250mg. The hardness of all the tablets 
was maintained to 4kg\cm
2. 
Formulation of tablets 
Weighed quantity of drug, polymer, organic acids (citric 
acid  and  Succinic  acid)  and  diluents  (lactose)  were 
passed  through  sieve  #  80  and  mixed  in  geometric 
proportion  using  a  mortar  and  pestle  followed  by 
lubrication using Magnesium stearate (0.5 %9)(table 1). 
250  mg  of  the  lubricated  physical  mixture  were 
compressed using a 10- station ‘Remek’ mini-press tablet 
punching  machine  using  flat  punches  (8mm 
diameter)
3,8,9,10.  Characteristics of the blend such as bulk 
density, compressibility index, and angle of repose were 
determined for each formulation
11, 12. 
Weight variation test was conducted as per specifications 
of  IP.  Hardness  of  the  tablet  was  kept  constant 
(approximately 4 kg/cm
2) for all the formulations. 
Evaluation  of  tablets:  The  tablets  were  subjected  to 
various evaluation tests such as  
1. Weight variation test: The tablets complied with the 
I.P. requirements in the test for weight variation. 
2. Friability test:  less than 0.1% 
3.  Drug content determination: 
The tablets were powdered, the tablet triturate equivalent 
to  40mg  of  propranolol  HCL  was  taken  in  100  ml 
volumetric flask, dissolved and volume was made up to 
the mark with simulated gastric fluid. From this solution, 
0.5 ml was pipetted into a 50 ml volumetric flask and 
volume  was  made  up  to  50  ml  with  simulated  gastric 
fluid. The absorbance was measured at 216 nm against 
reagent  blank  (0.1  N  HCl)  using  UV  (Elico-SL159) 
spectrophotometer. . The procedure was repeated for four 
more  tablets  of  the  same  formulation  and  the  average 
value of all five tablets was calculated. The drug content 
was calculated using the following equation. 
Amount of drug present = Absorbance ± Intercept / slope 
´ Dilution Factor  
In-vitro dissolution profile
 
Dissolution  studies  were  carried  out  by  USP-Type  II 
method at 37
0 ± 0.5
0 C.  The paddle was set to rotate at 
50 rpm.  One tablet, previously weighed, was kept in the 
dissolution media. The dissolution media, acidic buffer 
pH 1.2 for 12 hours and Phosphate buffer, pH 7.4 for 12 
hours  were  used.    5ml  of  samples  were  withdrawn  at 
each  hour  with  replacement  and  diluted  to  50ml  and 
absorbance  was  measured  at  216nm  in  a  UV  (Elico-
SL159) spectrophotometer.
13, 14,15 
 
 
 
RESULTS AND DISCUSSION 
Propranolol  HCl  is  a  useful  model  drug  to  test  the 
formulation concept because of its distinct pH-dependent 
solubility (mg). 
The  solubility  of  Propranolol  HCl  at  pH  2.0  is 
120.5224mg/ml; at pH 3.6 it is 71.2462mg/ml, at pH 6.0 
it decreases to about 63.5386 mg/ml and at basic pH 8.0 
it reduces to 63.0042 mg/ml.  Due to this pH-dependent 
solubility a remarkable difference in the resulting drug 
release  from  HPMC  tablet  was  observed  in  0.1N  HCl 
and in Phosphate buffer pH 7.4 solutions.  
Hydroxy Propyl Methyl cellulose polymer was used as a 
matrix  former  in which the drug Propranolol HCl was 
embedded.  The  drug:  polymer  ratio  were 
1:1,1:1.5,1:2,1:2.5,1:3  for  Hydroxy  propyl  methyl 
cellulose polymer. The drug: polymer ratio of 1:3 was 
selected  as  an  optimised  formula.  To  this  optimised 
formula, organic acids such as citric acid and Succinic 
acid were added. 
In  the  case  of  highly  swellable  HPMC  matrix  tablets 
(Table-I  formulation  No.  5),  approximately  7.7%  and 
4.6% of the drug was released after 1 hour in 0.1N HCl 
and Phosphate buffer respectively. After 8 hours, 48% of 
the drug was released in 0.1N HCl versus only 20% was 
released in Phosphate buffer solution, pH 7.4. (Shown in 
graph 1).   
The reason for this behaviour is that HPMC swells to a 
significant extent upon contact with the release medium.  
The  drug  is  not  predominantly  released  by  diffusion 
through water-filled pores but by diffusion through the 
swollen polymer  network.  In addition the swelling of 
HPMC polymer matrix also plays an important role. 
Hence  the  approach  to  adjust  the  release  profile  of 
weakly basic drugs in Phosphate buffer to that in 0.1N 
HCl was based on the addition of organic acids to create 
a  constant  acidic  microenvironment  inside  the  tablets.  
Ideally,  these  acids  should  dissolve  rather  slowly  to 
remain within the tablet during the entire period of drug 
release  independent of the pH value of the dissolution 
medium, the pH inside the tablet matrix was expected to 
be acidic and thus the solubility of the weakly basic drug 
to  be  high.    In  this  case,  drug  release  should  be  pH-
independent.    For  this  purpose,  substances  with  high 
acidic  strength  (low  pKa  value)  and  relatively  low 
solubility  in  0.1N  HCl  are  suitable.  Citric  acid  and 
Succinic  acids  were  selected.  In  addition,  the  organic 
acids can act as pore-formers at high pH values. 
The  addition  of  organic  acids  to  HPMC-based  matrix 
systems  significantly  increased  the  drug  release  in 
Phosphate  buffer  (pH  7.4)  with  increasing  amount  of 
organic  acids  (10  to  80  mg).  The  resulting  release 
profiles almost overlapped with the ones in 0.1N HCl.  Jayanthi et al / IJRAP 2011, 2 (2) 577-580 
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This  is  in  good  agreement  with  above  described 
hypothesis of a constant micro-environmental pH within 
the tablets. 
The amount of organic acids added to the system had no 
effect  on  the  drug  release  rate  in  0.1N  HCl.  The 
explanation  for  this  phenomenon  might  be  as  follows. 
The polymer HPMC swells to a significant extent upon 
contact with release medium and hence the water filled 
pores  are  rapidly  closed  due  to  the  swelling  of  the 
hydrogel. But the amount of imbibing bulk fluid is much 
higher in case of Phosphate
 buffer pH 7.4; this leads to 
higher  amount  of  hydroxide  ions  entering  the  tablet, 
resulting in higher micro environment pH values lead to 
higher solubility of the organic acids. Hence creation of 
additional water filled pores and thus to higher force for 
diffusion with increasing amount of incorporated organic 
acids (The formation of water-filled pores increases and 
thus the resulting release rate increases).  Furthermore, 
the effect of the organic acid was investigated .In all the 
case  the  addition  of  organic  acid  lead  to  a  significant 
increase  in  drug  release  in  Phosphate  buffer  pH  7.4. 
However,  when  compared  to  citric  acid,  Succinic  acid 
based  formulation  shows  slight  increase  in  the  drug 
release rate, which may be attributed to the lower pKa 
value of Succinic acid.     
CONCLUSION 
The use of HPMC matrices makes possible a sustained 
release  of  Propranolol  hydrochloride  with  coupled 
dissolution  mechanism  of  diffusion  and  essentially 
independent  of  pH.  The  addition  of  Succinic  acid 
resulted  in  a  slight  increase  in  the  drug  release  in 
phosphate buffer pH 7.4 when compared to citric acid, 
which  could  be  attributed  to  the  lower  pKa  value  of 
Succinic acid. 
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Table 1: Tablet formulations 
 
Formulation 
Code 
FORMULATION INGREDIENTS* 
Propranolol 
Hydrochloride 
HPMC 
 4000 CPS 
Lactose 
 
Magnesium 
stearate 
Citric 
acid 
Succinic 
acid 
F1  40  40  168.5  1.5  -  - 
F2  40  60  148.5  1.5  -  - 
F3  40  80  128.5  1.5  -  - 
F4  40  100  108.5  1.5  -  - 
F5  40  120  88.5  1.5  -  - 
FC10  40  120  78.5  1.5  10  - 
FC20  40  120  68.5  1.5  20  - 
FC40  40  120  48.5  1.5  40  - 
FC80  40  120  8.5  1.5  80  - 
FS10  40  120  78.5  1.5  -  10 
FS20  40  120  68.5  1.5  -  20 
FS40  40  120  48.5  1.5  -  40 
FS80  40  120  8.5  1.5  -  80 
*All quantities are in milligrams/tablet 
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          Graph 1 
IN VITRO RELEASE PROFILE OF FORMULATION F5 - pH 1.2 & 7.4 
 
     
 
 
  Graph 2 
IN VITRO DISSOLUTION PROFILE OF FORMULATIONS FS10, FS20, FS40, FS80 
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